bf/NYSE:BIO_icon.jpeg

NYSE:BIO.B

Bio-Rad Laboratories, Inc.

  • Stock

USD

Last Close

315.17

26/07 20:00

Market Cap

8.01B

Beta: -

Volume Today

243.33K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
77.81M
-
88.84M
14.18%
113.09M
27.29%
28.13M
75.13%
114.74M
307.96%
361.00M
214.62%
1.76B
387.17%
3.81B
116.43%
4.25B
11.55%
-3.63B
185.44%
-637.32M
82.43%
depreciation and amortization
147.16M
-
149.89M
1.86%
131.85M
12.04%
142.90M
8.38%
148.68M
4.05%
138.09M
7.13%
134.24M
2.79%
138.13M
2.90%
133.80M
3.13%
137.30M
2.61%
192.40M
40.14%
deferred income tax
10.83M
-
11K
99.90%
-14.03M
127,618.18%
-30.43M
116.94%
-40.93M
34.50%
118.93M
390.58%
-35.60M
129.93%
-41.60M
16.85%
-51.20M
23.08%
-1.24B
2,325%
-322.60M
74.02%
stock based compensation
13.70M
-
14.90M
8.76%
17M
14.09%
19.70M
15.88%
23.40M
18.78%
27.80M
18.80%
35.60M
28.06%
41.60M
16.85%
51.20M
23.08%
60.90M
18.95%
61.30M
0.66%
change in working capital
-66.61M
-
21.70M
132.58%
-51.82M
338.81%
-10.37M
79.99%
-155.54M
1,400.39%
-37.30M
76.02%
55.39M
248.51%
51.68M
6.70%
13.93M
73.04%
-407.04M
3,021.60%
-127.63M
68.64%
accounts receivables
-24.20M
-
11.10M
145.87%
-39M
451.35%
12.50M
132.05%
-64.10M
612.80%
59.70M
193.14%
1.60M
97.32%
-15M
1,037.50%
-20.40M
36%
-87.40M
328.43%
11.40M
113.04%
inventory
-33.40M
-
5.80M
117.37%
-54.20M
1,034.48%
-57.10M
5.35%
-47.70M
16.46%
-12.90M
72.96%
24.20M
287.60%
-52.10M
315.29%
46.10M
188.48%
-158.80M
444.47%
-46.30M
70.84%
accounts payables
33.20M
-
-9.90M
129.82%
28.60M
388.89%
30.10M
5.24%
7.80M
74.09%
-45.60M
684.62%
10.60M
123.25%
124.70M
1,076.42%
69.90M
43.95%
-94.20M
234.76%
-51.80M
45.01%
other working capital
-42.21M
-
14.70M
134.83%
12.78M
13.07%
4.13M
67.66%
-51.55M
1,347.16%
-38.50M
25.31%
18.99M
149.33%
-5.92M
131.18%
-81.67M
1,279.06%
-66.64M
18.40%
-40.93M
38.57%
other non cash items
-7.41M
-
-2.03M
72.58%
-9.88M
386.13%
66.51M
772.95%
13.54M
79.65%
-323.02M
2,486.38%
-1.49B
361.40%
-3.42B
129.52%
-3.74B
9.25%
5.27B
241.08%
1.21B
77.07%
net cash provided by operating activities
175.48M
-
273.31M
55.75%
186.21M
31.87%
216.43M
16.23%
103.89M
52.00%
285.49M
174.82%
457.90M
60.39%
575.33M
25.65%
656.52M
14.11%
194.45M
70.38%
374.94M
92.83%
investments in property plant and equipment
-113.70M
-
-136.48M
20.04%
-113.37M
16.93%
-141.57M
24.87%
-115.13M
18.68%
-129.83M
12.77%
-98.53M
24.11%
-98.92M
0.39%
-120.80M
22.12%
-114.16M
5.50%
-156.68M
37.25%
acquisitions net
-72.05M
-
-44.63M
38.06%
-4.36M
90.24%
-14.16M
225.18%
-76.64M
441.09%
6.96M
109.09%
-79.39M
1,239.95%
-96.66M
21.75%
-125.52M
29.86%
-100.75M
19.73%
2.71M
102.69%
purchases of investments
-386.71M
-
-205.75M
46.80%
-294.50M
43.14%
-278.07M
5.58%
-282.66M
1.65%
-370.75M
31.17%
-450.84M
21.60%
-345.11M
23.45%
-1.31B
278.16%
-2.06B
57.86%
-689.04M
66.56%
sales maturities of investments
565.83M
-
196.12M
65.34%
249.49M
27.21%
219.88M
11.87%
299.77M
36.33%
266K
99.91%
331.53M
124,536.09%
368.06M
11.02%
766.90M
108.36%
1.07B
39.01%
361.28M
66.11%
other investing activites
1.21M
-
225K
81.47%
-4.13M
1,936%
48K
101.16%
-914K
2,004.17%
306.37M
33,620.02%
88.33M
71.17%
112.38M
27.22%
52K
99.95%
1.52M
2,825%
501.94M
32,900.59%
net cash used for investing activites
-5.42M
-
-190.51M
3,414.31%
-166.87M
12.41%
-213.88M
28.17%
-175.57M
17.91%
-186.98M
6.50%
-208.89M
11.72%
-60.25M
71.16%
-784.44M
1,201.97%
-1.21B
53.94%
20.21M
101.67%
debt repayment
-300.23M
-
-253K
99.92%
-282K
11.46%
-303K
7.45%
-316K
4.29%
-2.96M
837.03%
-643K
78.28%
-426.94M
66,297.82%
-3.02M
99.29%
-510K
83.11%
-467K
8.43%
common stock issued
11.24M
-
15.05M
33.94%
8.24M
45.28%
11.28M
36.96%
7.29M
35.34%
3.83B
-
20.20M
99.47%
35.28B
174,580.66%
69.59B
97.23%
18.48M
99.97%
common stock repurchased
-2.92M
-
-48.91M
1,575.07%
-28M
42.75%
-100.00M
257.16%
-50.00M
50.00%
-215.68M
331.38%
-428.73M
98.78%
dividends paid
-4.37M
-
-3.83B
-
-20.20M
99.47%
-35.28B
174,580.66%
-68.18B
93.25%
-100.10B
46.81%
other financing activites
-22.71M
-
-3.11M
86.31%
627K
120.17%
-1.96M
412.12%
657K
133.57%
3.19M
386.00%
5.88M
84.31%
3.90M
33.71%
-2.41M
161.80%
-212.13M
8,698.59%
100.09B
47,280.59%
net cash used provided by financing activities
-311.70M
-
11.69M
103.75%
8.58M
26.59%
9.02M
5.12%
341K
96.22%
-48.68M
14,375.66%
-22.76M
53.25%
-523.04M
2,198.27%
-55.43M
89.40%
973.58M
1,856.44%
-425.65M
143.72%
effect of forex changes on cash
9.80M
-
-12.79M
230.44%
16.38M
228.04%
-12.86M
178.52%
-1.09M
91.49%
-655K
40.13%
2.24M
441.53%
12.43M
455.52%
-12.64M
201.68%
2.98M
123.59%
321K
89.23%
net change in cash
-131.84M
-
81.70M
161.97%
44.30M
45.78%
-1.28M
102.90%
-72.44M
5,537.35%
49.18M
167.89%
228.49M
364.58%
4.46M
98.05%
-195.98M
4,490.28%
-36.59M
81.33%
-30.26M
17.29%
cash at beginning of period
463.39M
-
331.55M
28.45%
413.25M
24.64%
457.55M
10.72%
456.26M
0.28%
384.98M
15.62%
434.16M
12.77%
662.65M
52.63%
667.12M
0.67%
471.13M
29.38%
434.23M
7.83%
cash at end of period
331.55M
-
413.25M
24.64%
457.55M
10.72%
456.26M
0.28%
383.82M
15.88%
434.16M
13.12%
662.65M
52.63%
667.12M
0.67%
471.13M
29.38%
434.54M
7.77%
403.97M
7.04%
operating cash flow
175.48M
-
273.31M
55.75%
186.21M
31.87%
216.43M
16.23%
103.89M
52.00%
285.49M
174.82%
457.90M
60.39%
575.33M
25.65%
656.52M
14.11%
194.45M
70.38%
374.94M
92.83%
capital expenditure
-113.70M
-
-136.48M
20.04%
-113.37M
16.93%
-141.57M
24.87%
-115.13M
18.68%
-129.83M
12.77%
-98.53M
24.11%
-98.92M
0.39%
-120.80M
22.12%
-114.16M
5.50%
-156.68M
37.25%
free cash flow
61.78M
-
136.83M
121.49%
72.84M
46.77%
74.86M
2.78%
-11.24M
115.02%
155.67M
1,484.68%
359.37M
130.86%
476.41M
32.57%
535.72M
12.45%
80.29M
85.01%
218.26M
171.84%

All numbers in USD (except ratios and percentages)